The History of Antibodies

Total Page:16

File Type:pdf, Size:1020Kb

The History of Antibodies The History of Antibodies Antibodies are large, characteristic Y-shaped molecules and arguably one of the quantities outside of the body; these ‘monoclonal antibodies’ paved the way for most iconic structures in all of science. They are produced by plasma cells of the the widespread use of antibodies as a research tool. More recently, monoclonal Enabling Legendary Discovery™ immune system and have the ability to specifically bind an almost limitless variety antibodies are proving themselves to be remarkably effective in the clinic, of target molecules, which enables them to neutralize toxins and pathogens like particularly for the treatment of certain types of cancer and autoimmune disease. bacteria or viruses. Antibodies were originally described in the late 1800s as the As of 2015, the global monoclonal antibody market is estimated at US $75 billion, active component of antiserum and as such are a key component of most types of and this figure is projected to increase substantially over the coming years. This immune response. In ground-breaking work in the 1970s, scientists developed poster provides an overview of important historical milestones in the discovery of techniques to produce antibodies of a defined specificity artificially and in vast antibodies and their development as therapeutics. l a n io at Genetic basis of class switching: Alfred Nisonhoff Pr N . oc he A Ac eedings of t S and colleagues identify identical variable regions ad es U emy o cienc in IgM and IgG antibodies in a patient with f S multiple myeloma, indicating that a genetic switch event must have happened15. Enid W. Silverton, Manuel A. Navia and David R. Davies present the first Tai Te Wu and Elvin Kabat discover the three-dimensional structure of an complementarity-determining regions immunoglobulin20. of antibodies14. First checkpoint inhibitors in cancer: Diphtheria anti-serum: Emil von Behring Jim Allison and colleagues show that and Shibasaburo Kitasato demonstrate an antibody against CTLA-4 enables Nucleus Medical Media/Nature Publishing Group that serum from infected animals can be Radioimmunoassay: Rosalyn Yalow and Solomon Leonard Herzenberg and mice to reject solid tumor grafts28. used to treat and prevent infection in Berson develop an antibody-based system to colleagues use fluorescently Mary Evans Picture Library/Alamy Stock Photo 9 Ronald Levy and colleagues use Greg Winter and colleagues develop other animals1,2. quantify insulin present in blood plasma . conjugated antibodies to sort B cells with a flow cytometer17. an anti-idiotype monoclonal the first fully humanized antibody25. antibody to successfully treat Tasuku Honjo and colleagues identify B cell lymphoma21. Use of antibodies as an analytical tool: activation induced cytidine deaminase Robin Coombs, Arthur Mourant and Robert (AID) as a key enzyme in class switching29. Race develop the Coombs test, which detects Gerald Edelman and colleagues David Schatz, Majorie Oettinger 5 describe the covalent structure Nobumichi Hozumi and and David Baltimore isolate antibodies to rhesus factor in the blood . 13 of an entire antibody molecule . Susumu Tonegawa demonstrate Sherie Morrison et al. and recombination-activating gene 1 the somatic rearrangement of Michael Neuberger et al. (RAG-1) and show that it First antibody–drug conjugate: gemtuzumab Gustav Nossal and Joshua Lederberg 26 immunoglobulin genes19. generate chimeric antibodies23,24. activates V(D)J recombination . ozogamicin receives FDA approval for the demonstrate that plasma cells produce treatment of acute myelogenous leukemia. 8 antibodies of a single specificity . It is later withdrawn from market. 1890 1900 1945 1947 1957 1958 1960 1965 1966 1969 1970 1971 1972 1975 1976 1977 1982 1983 1984 1985 1986 1989 1993 1996 1998 2000 2001 2011 Astrid Fagraeus shows Max Cooper and colleagues identify the Georges Köhler and César Milstein fuse First approval of a monoclonal antibody First clinical checkpoint inhibitor: that plasma cells bursa of Fabricius (a unique lymphoid organ myeloma cells with B cells, thereby for use in humans: the anti-CD3 Ipilimumab (anti-CTLA-4) receives U.S. FDA produce antibodies6. in birds) as the organ producing B cells10. generating immortal hybridomas that antibody muromonab-CD3 receives approval for the treatment of melanoma. secrete antibodies of a single specificity18. U.S. FDA approval for use in preventing transplant rejection. Paul Ehrlich presents the ‘side chain model’, Husband-and-wife team Kimishige Approval of first monoclonal antibody for proposing that cells can express a wide variety and Teruko Ishizaka discover IgE11,12. of side-chains that can be shed into the blood the targeted treatment of a solid tumor: and act as antitoxins or ‘antibodies’3,4. The anti-Her2 monoclonal antibody trastuzumab gains U.S. FDA approval for First monoclonal antibody in inflammatory disease: the treatment of metastatic breast cancer. Eva Engvall and Peter Perlman Marc Feldmann and Ravinder Maini show that the Clonal selection theory: Sir Frank Macfarlane develop the enzyme-linked anti-TNF antibody cA2 (later registered as infliximab) Burnet extends the idea that antibody-producing immunosorbent assay (ELISA)16. is effective in patients with rheumatoid arthritis27. cells make antibodies of a single specificity by predicting that these cells proliferate in response to antigen, thus creating ‘clones’7. Photo reproduced courtesy of Celia Milstein and the MRC Laboratory of Molecular Biology, Cambridge, UK Antibody-related Nobel prizes 1901 Emil von Behring for ‘the development of serum therapy’. n io First description of a potently lytic therapeutic t 1908 Paul Ehrlich ‘in recognition of … work on immunity’. a d n monoclonal antibody: Herman Waldmann and colleagues u o 1972 Gerald Edelman and Rodney Porter ‘for their discoveries concerning the l F show that CAMPATH-1 (later registered as alemtuzumab) be No can fix human complement and eliminate lymphocytes22. chemical structure of antibodies’. © ® The 1977 Rosalyn Yalow ‘…for the development of radioimmunoassays of peptide hormones’. 1984 Niels K. Jerne, Georges J. F. Köhler and César Milstein ‘for theories concerning the Walter and Eliza Hall Institute of Medical Research, specificity in development and control of the immune system and the discovery of Courtesy of Stefan H. E. Kaufmann. E. H. Stefan of Courtesy Melbourne, Australia. the principle for production of monoclonal antibodies’. 1987 Susumu Tonegawa ‘for his discovery of the genetic principle for generation of antibody diversity’. BioLegend References 181, 1419–1420 (1958). 16. Engvall, E. & Perlmann, P. Enzyme-linked immunosorbent assay (ELISA) 23. Morrison et al. Chimeric human antibody molecules: mouse antigen-binding Advisors 9. Yalow, R. S. & Berson, S. A. Immunoassay of endogenous plasma insulin in quantitative assay of immunoglobulin G. Immunochemistry 8, 871–874 domains with human constant region domains. Proc. Natl Acad. Sci. USA 81, BioLegend develops and manufactures highly recognized, world-class antibodies and reagents 1., Behring E. & Kitasato, S. Über das Zustandekommen der Diphtherie- man. J. Clin. Invest. 39, 1157–1175 (1960). (1971). 6851–6855 (1984). Marc Feldmann, University of Oxford, UK | Andrew J. T. The poster content is peer reviewed, at an outstanding value to customers for biomedical research. Our broad product portfolio Immunität und der Tetanus-Immunität bei Thieren. Dtsch. Med. Wschr 16, 10. Cooper, M. D. et al. Delineation of the thymic and bursal lymphoid systems 17. Julius, M. H., Masuda, T. & Herzenberg, L. A. Demonstration that antigen- 24. Neuberger, M. S., Williams, G. T. & Fox, R. O. Recombinant George, Brunel University, UK | Philip D. Hodgkin, WEHI, editorially independent and the sole 1113–1114 (in German) (1890). in the chicken. Nature 205, 143–146 (1965). binding cells are precursors of antibody-producing cells after purification antibodies possessing novel effector functions. Nature 312, 604–608 responsibility of Macmillan Publishers includes flow cytometry, cell biology, and biofunctional molecules for research in immunology, 2. Behring, E. Untersuchungen über das Zustandekommen der Diphtherie- 11. Ishizaka, K. et al. Physico-chemical properties of human reaginic antibody: with a fluorescence-activated cell sorter. Proc. Natl Acad. Sci. USA 69, (1984). Australia | Daniel H. Kaplan, University of Pittsburgh, Dtsch. Med. Wschr. J. Immunol. et al. Limited. neuroscience, cancer, cell biology, stem cells, and more. Our aggressive product development Immunität bei Thieren. 16, IV. Presence unique immunoglobulin carrier reaginic antibody. 1934–1938 (1972). 25. Jones, P. T. Replacing the complementarity-determining regions in a USA | Stefan H. E. Kaufmann, Max Planck Institute for 1145–1147 (in German) (1890). 97, 75–85 (1966). 18. Köhler, G. & Milstein, C. Continuous cultures of fused cells secreting human antibody with those from a mouse. Nature 321, 522–525 (1986). Infection Biology, Germany | Toshiaki Kawakami, La Jolla Edited by Zoltan Fehervari and Alexandra program, accomplished through technology licensing, collaborations, and internal research 3. Ehrlich, P. Die Seitenkettentheorie und ihre Gegner. Münch. Med. Wschr. 18, 12. Ishizaka, K. et al. Physico-chemical properties of human reaginic antibody: antibody of predefined specificity. Nature 256, 495–497 (1975). 26. Schatz, D. G. et al. The V(D)J Recombination Activating Gene, RAG-1. 2123 (in German) (1901). V. Correlation of reaginic activity with γ-E-globulin antibody. J. Immunol. 97, 19. Hozumi, N. & Tonegawa,
Recommended publications
  • Unrestricted Immigration and the Foreign Dominance Of
    Unrestricted Immigration and the Foreign Dominance of United States Nobel Prize Winners in Science: Irrefutable Data and Exemplary Family Narratives—Backup Data and Information Andrew A. Beveridge, Queens and Graduate Center CUNY and Social Explorer, Inc. Lynn Caporale, Strategic Scientific Advisor and Author The following slides were presented at the recent meeting of the American Association for the Advancement of Science. This project and paper is an outgrowth of that session, and will combine qualitative data on Nobel Prize Winners family histories along with analyses of the pattern of Nobel Winners. The first set of slides show some of the patterns so far found, and will be augmented for the formal paper. The second set of slides shows some examples of the Nobel families. The authors a developing a systematic data base of Nobel Winners (mainly US), their careers and their family histories. This turned out to be much more challenging than expected, since many winners do not emphasize their family origins in their own biographies or autobiographies or other commentary. Dr. Caporale has reached out to some laureates or their families to elicit that information. We plan to systematically compare the laureates to the population in the US at large, including immigrants and non‐immigrants at various periods. Outline of Presentation • A preliminary examination of the 609 Nobel Prize Winners, 291 of whom were at an American Institution when they received the Nobel in physics, chemistry or physiology and medicine • Will look at patterns of
    [Show full text]
  • “Schrödinger at 75: the Future of Biology International Meeting”?
    DO YOU WANT TO BE PART OF “Schrödinger at 75: The Future of Biology International Meeting”? On 5-6 September 2018 Trinity College Dublin will hold “Schrödinger at 75: The Future of Life” international meeting. The purpose is to mark the 75th anniversary of a series of visionary public lectures entitled “What is Life?” by Nobel laureate, physicist Erwin Schrödinger, who was then Director of Theoretical Physics at the Dublin Institute for Advanced Studies (DIAS). When Schrödinger gave his original lectures in 1943 in Trinity College Dublin, the basis for heredity was the urgent unsolved question. Speakers will address the current burning issues in biology—including the basis of the mind and consciousness, ageing, gene editing, synthetic biology, bioenergetics and the origin of life—and will recapture the spirit of Schrödinger’s lectures by exploring the future of biology. The meeting will build on the strong historical importance of Ireland and Trinity College Dublin in the foundations of 20th century science, and use it as a platform for the world’s leading researchers from all areas of biology to set the scientific agenda, as they see it, for the 21st century. THE ORGANISING COMMITTEE IS HOPING TO ENGAGE TRINITY STUDENTS IN THIS UNIQUE EVENT. Programme The 75th anniversary meeting will focus on the future of questions at the centre of life today. Specific themes include systems biology, bioenergetics, brain and mind, memory, consciousness, ageing, human evolution, and artificial intelligence. It will be a two-day scientific meeting accompanied by a major lecture by the renowned philosopher, cognitive scientist, and author Daniel Dennett on the Future of Life.
    [Show full text]
  • Cambridge's 92 Nobel Prize Winners Part 2 - 1951 to 1974: from Crick and Watson to Dorothy Hodgkin
    Cambridge's 92 Nobel Prize winners part 2 - 1951 to 1974: from Crick and Watson to Dorothy Hodgkin By Cambridge News | Posted: January 18, 2016 By Adam Care The News has been rounding up all of Cambridge's 92 Nobel Laureates, celebrating over 100 years of scientific and social innovation. ADVERTISING In this installment we move from 1951 to 1974, a period which saw a host of dramatic breakthroughs, in biology, atomic science, the discovery of pulsars and theories of global trade. It's also a period which saw The Eagle pub come to national prominence and the appearance of the first female name in Cambridge University's long Nobel history. The Gender Pay Gap Sale! Shop Online to get 13.9% off From 8 - 11 March, get 13.9% off 1,000s of items, it highlights the pay gap between men & women in the UK. Shop the Gender Pay Gap Sale – now. Promoted by Oxfam 1. 1951 Ernest Walton, Trinity College: Nobel Prize in Physics, for using accelerated particles to study atomic nuclei 2. 1951 John Cockcroft, St John's / Churchill Colleges: Nobel Prize in Physics, for using accelerated particles to study atomic nuclei Walton and Cockcroft shared the 1951 physics prize after they famously 'split the atom' in Cambridge 1932, ushering in the nuclear age with their particle accelerator, the Cockcroft-Walton generator. In later years Walton returned to his native Ireland, as a fellow of Trinity College Dublin, while in 1951 Cockcroft became the first master of Churchill College, where he died 16 years later. 3. 1952 Archer Martin, Peterhouse: Nobel Prize in Chemistry, for developing partition chromatography 4.
    [Show full text]
  • The Rhesus Factor and Disease Prevention
    THE RHESUS FACTOR AND DISEASE PREVENTION The transcript of a Witness Seminar held by the Wellcome Trust Centre for the History of Medicine at UCL, London, on 3 June 2003 Edited by D T Zallen, D A Christie and E M Tansey Volume 22 2004 ©The Trustee of the Wellcome Trust, London, 2004 First published by the Wellcome Trust Centre for the History of Medicine at UCL, 2004 The Wellcome Trust Centre for the History of Medicine at University College London is funded by the Wellcome Trust, which is a registered charity, no. 210183. ISBN 978 0 85484 099 1 Histmed logo images courtesy Wellcome Library, London. Design and production: Julie Wood at Shift Key Design 020 7241 3704 All volumes are freely available online at: www.history.qmul.ac.uk/research/modbiomed/wellcome_witnesses/ Please cite as : Zallen D T, Christie D A, Tansey E M. (eds) (2004) The Rhesus Factor and Disease Prevention. Wellcome Witnesses to Twentieth Century Medicine, vol. 22. London: Wellcome Trust Centre for the History of Medicine at UCL. CONTENTS Illustrations and credits v Witness Seminars: Meetings and publications;Acknowledgements vii E M Tansey and D A Christie Introduction Doris T Zallen xix Transcript Edited by D T Zallen, D A Christie and E M Tansey 1 References 61 Biographical notes 75 Glossary 85 Index 89 Key to cover photographs ILLUSTRATIONS AND CREDITS Figure 1 John Walker-Smith performs an exchange transfusion on a newborn with haemolytic disease. Photograph provided by Professor John Walker-Smith. Reproduced with permission of Memoir Club. 13 Figure 2 Radiograph taken on day after amniocentesis for bilirubin assessment and followed by contrast (1975).
    [Show full text]
  • Bourne Lecture
    “One Medicine: the Continuum of Medicine, Veterinary Medicine and Biomedical Science”. Bourne Lecture. 12th February 2007. St Georges Medical School , Grenada. Ian McConnell , Professor of Veterinary Science, Department of Veterinary Medicine, University of Cambridge, England, United Kingdom. Introduction. Chancellor, Provost , Ladies and Gentlemen. Thank you , Provost, for your generous introduction. It is indeed an honour to be invited to give this years Bourne lecture in memory of Geoffrey Bourne . Geoffrey Bourne , your first Vice Chancellor who as an educator and scientist who had the vision to create here in this marvellous country of Grenada a most remarkable medical school which later evolved under the leadership of Keith Taylor, as Vice Chancellor, into what is today- a thriving and confident young University. St George’s University is an internationally recognised institution of higher education which has set a dynamic global perspective and can rightly claim to be a stratgically important landmark of learning in the West Indies. In this lecture I am going to address the topic of “ One Medicine”. I have chosen this as a topic because it seems appropriate to the St. George’s Medical School and the close relationship it has with the veterinary school. The development of the veterinary school owes much to the foresight and drive of Peter Bourne, who as Vice Chancellor, fostered the development of veterinary medicine. In the long history of both the Medical and the Veterinary Professions and the education of undergraduates in both there has always been a healthy interaction between medicine, veterinary medicine as well as biomedical science. The co-location of a medical school with a veterinary school which you have here is one way to promote this interaction .
    [Show full text]
  • Genetic Testing
    GENETIC TESTING The transcript of a Witness Seminar held by the Wellcome Trust Centre for the History of Medicine at UCL, London, on 13 July 2001 Edited by D A Christie and E M Tansey Volume 17 2003 CONTENTS Illustrations v Introduction Professor Peter Harper vii Acknowledgements ix Witness Seminars: Meetings and publications xi E M Tansey and D A Christie Transcript Edited by D A Christie and E M Tansey 1 References 73 Biographical notes 91 Glossary 105 Index 115 ILLUSTRATIONS Figure 1 Triploid cells in a human embryo, 1961. 20 Figure 2 The use of FISH with DNA probes from the X and Y chromosomes to sex human embryos. 62 v vi INTRODUCTION Genetic testing is now such a widespread and important part of medicine that it is hard to realize that it has almost all emerged during the past 30 years, with most of the key workers responsible for the discoveries and development of the field still living and active. This alone makes it a suitable subject for a Witness Seminar but there are others that increase its value, notably the fact that a high proportion of the critical advances took place in the UK; not just the basic scientific research, but also the initial applications in clinical practice, particularly those involving inherited disorders. To see these topics discussed by the people who were actually involved in their creation makes fascinating reading; for myself it is tinged with regret at having been unable to attend and contribute to the seminar, but with some compensation from being able to look at the contributions more objectively than can a participant.
    [Show full text]
  • Cold Spring Harbor Symposia on Quantitative Biology
    COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY VOLUME LVII COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY VOLUME LVII The Cell Surface COLD SPRING HARBOR LABORATORY PRESS 1992 COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY VOLUME LVII 1992 by The Cold Spring Harbor Laboratory Press International Standard Book Number 0-87969-063-1 (cloth) International Standard Book Number 0-87969-064-X (paper) International Standard Serial Number 0091-7451 Library of Congress Catalog Card Number 34-8174 Printed in the United States of America All rights reserved COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY Founded in 1933 by REGINALD G. HARRIS Director of the Biological Laboratory 1924 to 1936 Previous Symposia Volumes I (1933) Surface Phenomena xxvII (1962) Basic Mechanisms in Animal Virus Biology II (1934) Aspects of Growth XXVIII (1963) Synthesis and Structure of Macromolecules III (1935) Photochemical Reactions XXIX (1964) Human Genetics IV (1936) Excitation Phenomena XXX (1965) Sensory Receptors V (1937) Internal Secretions XXXI (1966) The Genetic Code VI (1938) Protein Chemistry XXXII (1967) Antibodies VII (1939) Biological Oxidations XXXIII (1968) Replication of DNA in Microorganisms VIII (1940) Permeability and the Nature of Cell Membranes XXXIV (1969) The Mechanism of Protein Synthesis IX (1941) Genes and Chromosomes: Structure and Organi- XXXV (1970) Transcription of Genetic Material zation XXXVI (1971) Structure and Function of Proteins at the X (1942) The Relation of Hormones to Development Three-dimensional Level XI (1946)
    [Show full text]
  • Balcomk41251.Pdf (558.9Kb)
    Copyright by Karen Suzanne Balcom 2005 The Dissertation Committee for Karen Suzanne Balcom Certifies that this is the approved version of the following dissertation: Discovery and Information Use Patterns of Nobel Laureates in Physiology or Medicine Committee: E. Glynn Harmon, Supervisor Julie Hallmark Billie Grace Herring James D. Legler Brooke E. Sheldon Discovery and Information Use Patterns of Nobel Laureates in Physiology or Medicine by Karen Suzanne Balcom, B.A., M.L.S. Dissertation Presented to the Faculty of the Graduate School of The University of Texas at Austin in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy The University of Texas at Austin August, 2005 Dedication I dedicate this dissertation to my first teachers: my father, George Sheldon Balcom, who passed away before this task was begun, and to my mother, Marian Dyer Balcom, who passed away before it was completed. I also dedicate it to my dissertation committee members: Drs. Billie Grace Herring, Brooke Sheldon, Julie Hallmark and to my supervisor, Dr. Glynn Harmon. They were all teachers, mentors, and friends who lifted me up when I was down. Acknowledgements I would first like to thank my committee: Julie Hallmark, Billie Grace Herring, Jim Legler, M.D., Brooke E. Sheldon, and Glynn Harmon for their encouragement, patience and support during the nine years that this investigation was a work in progress. I could not have had a better committee. They are my enduring friends and I hope I prove worthy of the faith they have always showed in me. I am grateful to Dr.
    [Show full text]
  • ALMANAC October 31, 1972
    IN THIS ISSUE " The Week of the Three Nobel Prizes " FACILITIES: Vance Hall, Levy Pavilion, Williams Hall " Revising Admissions for Undergraduates (Wood) Volume 19, Number 10October 31, 1972 " COUNCIL: Agenda " BULLETINS " DEATHS Published weekly by the University of Pennsylvania Museum and the Penn-Columbia Soccer Game at Franklin Field. Saturday they will hold a box lunch on College Hall Green before the Penn-Columbia Football Game. A survey last year showed that visits to classrooms were the most popular feature of the annual Parents Day sponsored by the University's Annual Giving Program. Page 2 The most disappointing feature: visits to classrooms where a class had been canceled without notice or where an exam was in progress instead of a lecture or discussion. This year, faculty are urgently asked to advise their students in advance if November 17 will not be a normal day. RESIDENTIAL LEARNING PROPOSALS: NOVEMBER 20 NEWS IN BRIEF Faculty members and others interested in planning and proposing living/learning projects for the academic year 1973- PRESIDENT/ PROVOSTS STAFF: DR. THACKRAY 74 must contact Mrs. Margo Marshall, Director of Residential in the Office of the Vice Provost for Dr. Arnold Thackray, Chairman and Associate Professor Programs Undergraduate Studies, November 20. The deadline for the of the History and Sociology of Science, has been named a by follow-up written is November 30. A committee will review Faculty Assistant to the President and the Provost. He joins proposals all and make its recommendations at the Dr. Robert Zemsky in that title and succeeds Dr. Renee Fox, proposals beginning of the who is now Chairman of Sociology.
    [Show full text]
  • Download?Doi=10.1.1.693.9331&Rep=Rep1&Type=Pdf, 2010;
    bioRxiv preprint doi: https://doi.org/10.1101/726331; this version posted August 14, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. One-time learning and reverse salience signals with a Salience Affected Neural Network (SANN) Leendert A Remmelzwaal1* Y ¤, George F R Ellis2 Y ¤, Jonathan Tapson3 Y 1 Department of Electrical Engineering, University of Cape Town, Cape Town, Western Cape, South Africa 2 Department of Mathematics and Applied Mathematics, University of Cape Town, Cape Town, Western Cape, South Africa 3 MARCS Institute for Brain, Behaviour and Development, Western Sydney University, Sydney, Australia Y All three authors contributed equally to the first stage of this work [66] ¤ These authors equally took the lead in the further development presented here. * Corresponding author: [email protected] Abstract Standard artificial neural networks model key cognitive aspects of brain function, such as learning and classification, but they do not model the affective (emotional) aspects; however primary and secondary emotions play a key role in interactions with the physical, ecological, and social environment. These emotions are associated with memories when neuromodulators such as dopamine and noradrenaline affect entire patterns of synaptically activated neurons. Standard artificial neural networks (ANNs) do not model this non-local effect of neuromodulators, which are a significant feature in the brain (the associated `ascending systems' have been hard-wired into the brain by evolutionary processes). In this paper we present a salience-affected neural network (SANN) model which, at the same time as local network processing of task-specific information, includes non-local salience (significance) effects responding to an input salience signal.
    [Show full text]
  • Why Global Academic Competition Is Good for the U.S. Meet Stuyvesant
    WINTER 2010 SHIRLEY ANN JACKSON President, Rensselaer Polytechnic Institute Why Global Academic W. Brian Arthur Meet Stuyvesant Competition is On the Nature of Science Teacher Good for the U.S. Technology Elizabeth Fong Building communities, advancing science since 1817 • www.nyas.org Board of Governors Chair Vice Chair Treasurer JOHN E. SEXTON BRUCE S. MCEWEN JAY FURMAN President [ex offi cio] Secretary [ex offi cio] ELLIS RUBINSTEIN LARRY SMITH Governors SETH F. BERKLEY WILLIAM A. HASELTINE JEFFREY D. SACHS LEN BLAVATNIK STEVE HOCHBERG DAVID J. SKORTON NANCY CANTOR TONI HOOVER GEORGE E. THIBAULT ROBERT CATELL MORTON HYMAN IRIS WEINSHALL VIRGINIA W. CORNISH MADELEINE JACOBS ANTHONY WELTERS KENNETH L. DAVIS MEHMOOD KHAN FRANK WILCZEK ROBIN L. DAVISSON ABRAHAM M. LACKMAN DEBORAH E. WILEY BRIAN FERGUSON RUSSELL READ MICHAEL ZIGMAN BRIAN GREENE NANCY ZIMPHER International Governors Chairman Emeritus Honorary Life Governors MANUEL CAMACHO SOLIS TORSTEN N. WIESEL KAREN E. BURKE GERALD CHAN HERBERT J. KAYDEN RAJENDRA K. PACHAURI JOHN F. NIBLACK PAUL STOFFELS President’s Council PETER AGRE, Nobel Laureate & Univ. Prof. and Director, Johns Hopkins Malaria Research Inst., Dept. Molecular Microbiology and Immunology, Bloomberg School of Public Health RICHARD AXEL, Nobel Laureate & University Professor, Columbia Univ.; Investigator, HHMI LEE BABISS, Global Head, Pharma Research, Roche Pharmaceuticals DAVID BALTIMORE, Nobel Laureate & President Emeritus, Caltech On the cover: Dr. Shirley Ann Jackson, President, ETIENNE-EMILE BAULIEU, former President, French Academy of Sciences Rensselaer Polytechnic Institute. PAUL BERG, Nobel Laureate & Professor Emeritus, Dept. of Biochemistry, Stanford Univ. PHOTO: LONNY KALFUS LEN BLAVATNIK, Chairman, Access Industries GÜNTER BLOBEL, Nobel Laureate & Director, Laboratory for Cell Biology, Rockefeller Univ.
    [Show full text]
  • Research Organizations and Major Discoveries in Twentieth-Century Science: a Case Study of Excellence in Biomedical Research
    A Service of Leibniz-Informationszentrum econstor Wirtschaft Leibniz Information Centre Make Your Publications Visible. zbw for Economics Hollingsworth, Joseph Rogers Working Paper Research organizations and major discoveries in twentieth-century science: A case study of excellence in biomedical research WZB Discussion Paper, No. P 02-003 Provided in Cooperation with: WZB Berlin Social Science Center Suggested Citation: Hollingsworth, Joseph Rogers (2002) : Research organizations and major discoveries in twentieth-century science: A case study of excellence in biomedical research, WZB Discussion Paper, No. P 02-003, Wissenschaftszentrum Berlin für Sozialforschung (WZB), Berlin This Version is available at: http://hdl.handle.net/10419/50229 Standard-Nutzungsbedingungen: Terms of use: Die Dokumente auf EconStor dürfen zu eigenen wissenschaftlichen Documents in EconStor may be saved and copied for your Zwecken und zum Privatgebrauch gespeichert und kopiert werden. personal and scholarly purposes. Sie dürfen die Dokumente nicht für öffentliche oder kommerzielle You are not to copy documents for public or commercial Zwecke vervielfältigen, öffentlich ausstellen, öffentlich zugänglich purposes, to exhibit the documents publicly, to make them machen, vertreiben oder anderweitig nutzen. publicly available on the internet, or to distribute or otherwise use the documents in public. Sofern die Verfasser die Dokumente unter Open-Content-Lizenzen (insbesondere CC-Lizenzen) zur Verfügung gestellt haben sollten, If the documents have been made available under an Open gelten abweichend von diesen Nutzungsbedingungen die in der dort Content Licence (especially Creative Commons Licences), you genannten Lizenz gewährten Nutzungsrechte. may exercise further usage rights as specified in the indicated licence. www.econstor.eu P 02 – 003 RESEARCH ORGANIZATIONS AND MAJOR DISCOVERIES IN TWENTIETH-CENTURY SCIENCE: A CASE STUDY OF EXCELLENCE IN BIOMEDICAL RESEARCH J.
    [Show full text]